×

Immunostimulatory nucleic acids for the treatment of asthma and allergy

  • US 7,585,847 B2
  • Filed: 02/02/2001
  • Issued: 09/08/2009
  • Est. Priority Date: 02/03/2000
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for treating an asthmatic event in a hypo-responsive subject having allergic asthma, comprising:

  • administering to a hypo-responsive subject having allergic asthma a CpG immunostimulatory nucleic acid having the formula
    5′

    N1X1X2CGX3X4N2 3′

    wherein the cytosine of the CG dinucleotide is unmethylated, X1 and X2 are both purines and X3 and X4 are both pyrimidines, and N1 and N2 are nucleic acid sequences composed of 0-25 nucleotides each, in an effective amount for treating an asthmatic event,wherein the hypo-responsive subject is refractory to an asthma/allergy medicament, andwherein the CpG immunostimulatory nucleic acid is 8-100 nucleotides.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×